Physician profile
Bryan Roehl
NPI 1720248164
$14,754.80
in general payments reported to CMS, 2019-2025
32 companies · $580 in 2025
The $580 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.72 · 2020: $92.77 · 2021: $135 · 2022: $543 · 2023: $12K · 2024: $1,546 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $3,302 · Travel and Lodging: $3,145 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $3,301.61 |
| Travel and Lodging | $3,144.75 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,873.39 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Coloplast Corp | $1,285.63 | 2022-2023 | Altis |
| Minerva Surgical, INC | $429.32 | 2023-2025 | |
| Astellas Pharma US INC | $426.92 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $241.53 | 2024-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $238.79 | 2023-2025 | Myfembree |
| Abbvie INC. | $234.09 | 2020-2024 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $230.68 | 2023-2025 | |
| Myovant Sciences INC. | $78.25 | 2021-2022 | |
| Pfizer INC. | $76.00 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.79 | 2022-2025 | |
| Therapeuticsmd, INC. | $71.29 | 2020-2022 | |
| Organon LLC | $55.13 | 2021-2024 | |
| Scynexis, INC. | $47.90 | 2022 | |
| Merck Sharp & Dohme LLC | $43.12 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $39.43 | 2022-2025 | Vistaseal |
| Millicent US INC | $33.71 | 2023 | Intrarosa, Femring |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.91 | 2023-2024 | Xifaxan, Trulance |
| P Bar Medical LLC | $25.17 | 2025 | |
| Baxter Healthcare | $24.00 | 2025 | Perclot |
| Coopersurgical, INC. | $22.52 | 2022 | |
| Agile Therapeutics, INC. | $22.21 | 2024 | Twirla |
| Conmed Corporation | $19.70 | 2025 | Airseal |
| Depuy Synthes Sales INC. | $19.05 | 2021 | |
| Gynesonics, INC. | $19.01 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Vertex Pharmaceuticals Incorporated | $17.13 | 2025 | |
| Avion Pharmaceuticals | $14.72 | 2019 | |
| Solventum Corporation | $14.31 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ardelyx, INC. | $13.74 | 2023 | Ibsrela |
| Exact Sciences Corporation | $13.38 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $12.09 | 2022 | |
| Meditrina | $4.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Roehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.